跳到正文
原文
Novo Nordisk· @novonordisk · X·· 28 天前精选AI 评分60
AI 导读

诺和诺德公布一项III期试验数据,显示受试者在绝经各阶段的平均体重降幅为25%。公司称这一结果意味着绝经并不必然导致减重效果下降,完整数据见其新闻稿。

推荐理由

诺和诺德公布其III期试验中跨绝经阶段的平均减重数据,读者可据此了解该药在绝经女性群体中的减重表现。

正文

#PRESS: Menopause doesn't have to mean less weight loss. New phase 3 trial data show an average weight loss of 25% across menopause stages, offering women new hope for meaningful weight loss and lasting health.

Get all the details in our press release: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=918569

来源:Novo Nordisk · x.com